We appreciate the interest of Kaier et al in our publication. Clearly, we all agree that hospital-acquired infection is a serious health care issue deserving of the highest level of empirical inquiry.
"Effectiveness of a shielded ultraviolet C air disinfection system in an inpatient pharmacy of a tertiary care children's hospital" Lacks scientific evidence To the Editor:
We recently reviewed the Brief Report by Guimera et al. 1 The article concludes that a novel air purification system was effective in decreasing viable airborne microbes and that these units are advantageous over other technologies currently available. We disagree with both conclusions and are dismayed that this report was published.
In the conclusion of their article, the authors indicate that further studies would be required. However, the data collected during this initial study were not sufficient for them to conclude that this device was effective. The sample size of the study is concerning. Viable environmental monitoring is a snapshot in time, and the bioburden of a cleanroom is constantly changing. Although the sample size may have been statistically significant, the authors did not account for this issue. Because of the dynamics of a cleanroom, this limited data set does not show that the air purification system was the sole reason for the reduction in bioburden. To secure a truly significant data set upon which valid conclusions could be made, a weekly collection in all locations preinstallation and postinstallation for a year would be needed. This would provide representative data of the state of control in the cleanroom.
The article does not include critical information about the operating conditions of the cleanroom during sampling. Personnel are the greatest source of contamination in a sterile compounding controlled environment. The authors do not indicate whether the samples were collected under dynamic operating conditions or the number of people who were present in the room. This information is crucial to ensure that the preinstallation and postinstallation sampling occurred under the same conditions.
The study also indicates that there were no changes in cleaning or disinfection practices between the sampling points. However, there was no indication whether any other changes, such as garbing, material transfer procedures, or conduct or number of personnel and compounding procedures, occurred. Positive changes to these aspects could greatly reduce the amount of microbial contamination in a cleanroom.
Information regarding the media and incubation parameters was missing. The type of media used for sampling is important and should have been supplied. Incubation of the samples is another piece of critical information. The fungal samples were incubated under the same conditions as the bacterial samples, which at 32°C ± 2°C is warmer than would be expected for this type of sample. Ideally, the fungal incubation temperature is 22.5°C ± 2.5°C.
Information about USP Chapter 797 2 was misquoted in the introduction paragraph. The action level for an International Organization for Standardization (ISO) class 5 space is >1 CFU/m 3 , and an anteroom may be ISO class 7 or ISO class 8 depending on the types of buffer rooms it services. It was also indicated that viable airborne particles must be assessed as part of certification. This
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